Beta-myosin heavy chain myocytes are more resistant to changes in power output induced by ischemic conditions

Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H869-77. doi: 10.1152/ajpheart.00221.2005. Epub 2005 Sep 19.

Abstract

During ischemia intracellular concentrations of P(i) and H+ increase. Also, changes in myosin heavy chain (MHC) isoform toward beta-MHC have been reported after ischemia and infarction associated with coronary artery disease. The purpose of this study was to investigate the effects of myoplasmic changes of P(i) and H+ on the loaded shortening velocity and power output of cardiac myocytes expressing either alpha- or beta-MHC. Skinned cardiac myocyte preparations were obtained from adult male Sprague-Dawley rats (control or treated with 5-n-propyl-2-thiouracil to induce beta-MHC) and mounted between a force transducer and servomotor system. Myocyte preparations were subjected to a series of isotonic force clamps to determine shortening velocity and power output during Ca2+ activations in each of the following solutions: 1) pCa 4.5 and pH 7.0; 2) pCa 4.5, pH 7.0, and 5 mM P(i); 3) pCa 4.5 and pH 6.6; and 4) pCa 4.5, pH 6.6, and 5 mM P(i). Added P(i) and lowered pH each caused isometric force to decline to the same extent in alpha-MHC and beta-MHC myocytes; however, beta-MHC myocytes were more resistant to changes in absolute power output. For example, peak absolute power output fell 53% in alpha-MHC myocytes, whereas power fell only 38% in beta-MHC myocytes in response to elevated P(i) and lowered pH (i.e., solution 4). The reduced effect on power output was the result of a greater increase in loaded shortening velocity induced by P(i) in beta-MHC myocytes and an increase in loaded shortening velocity at pH 6.6 that occurred only in beta-MHC myocytes. We conclude that the functional response to elevated P(i) and lowered pH during ischemia is MHC isoform-dependent with beta-MHC myocytes being more resistant to declines in power output.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimetabolites / pharmacology
  • Energy Metabolism*
  • Hydrogen-Ion Concentration
  • Male
  • Muscle Contraction*
  • Myocardial Ischemia / physiopathology*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Myosin Heavy Chains / antagonists & inhibitors
  • Myosin Heavy Chains / metabolism*
  • Phosphates / metabolism
  • Propylthiouracil / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Ventricular Myosins / antagonists & inhibitors

Substances

  • Antimetabolites
  • MYH7 protein, rat
  • Phosphates
  • Propylthiouracil
  • Ventricular Myosins
  • Myosin Heavy Chains